| BCBS California | Tonic Motor Activation for Restless Legs Syndrome | 2026-03-01 |
| UHC UMR Medical and Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Airway Clearance Devices – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Computerized Dynamic Posturography – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Electromagnetic Therapy for Wounds – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Elevidys® (Delandistrogene Moxeparvovec-Rokl) – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Intensity-Modulated Radiation Therapy – Commercial and Individual Exchange Medical Policy | 2026-03-01 |